Jon Snodgres, Chief Financial Officer at REPLIGEN CORP (RGEN), sold 3,310 shares at $90.39 ($296K) on 2020-03-04, disclosed to the SEC on 2020-03-05.
Seasonal sale ($296k) by Chief Financial Officer — this insider has traded RGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.18 | 610 | $54K | 18.1% |
| 2 | $88.18 | 610 | $54K | 18.1% |
| 3 | $90.39 | 1,045 | $94K | 31.9% |
| 4 | $90.39 | 1,045 | $94K | 31.9% |
| Total | $89.58 avg | 3,310 | $296K | 100% |
| Filing → |
| RGEN | SELL | 2022-08-02 | $440K | — | Filing → |
| RGEN | SELL | 2021-05-18 | $81K | — | Filing → |
| RGEN | SELL | 2021-03-08 | $797K | — | Filing → |